Publicaciones en colaboración con investigadores/as de Hospital de Móstoles (21)

2024

  1. A system dynamics modelling and analytical framework for imported dengue outbreak surveillance and risk mapping

    Acta Tropica, Vol. 257

2023

  1. COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study

    Cancers, Vol. 15, Núm. 5

  2. Prone positioning in Covid-19 patients with acute respiratory distress syndrome and invasive mechanical ventilation

    Enfermeria Intensiva, Vol. 34, Núm. 2, pp. 80-89

2021

  1. Measuring Choroid Thickness as a Marker of Systemic Inflammation in Patients with Ankylosing Spondylitis

    Journal of Clinical Rheumatology, Vol. 27, Núm. 8, pp. E307-E311

2020

  1. AB0726 Choroidal Thickness Is a Biomarker a and Can Predict The Response to Treatment in Ankylosing Spondylitis

    Annals of the Rheumatic Diseases, Vol. 79, Núm. Suppl 1, pp. 1657.1-1658

  2. Adaptation and validation of the ICU Mobility Scale in Spain

    Enfermeria Intensiva, Vol. 31, Núm. 3, pp. 131-146

  3. Choroidal Thickness Is a Biomarker Associated With Response to Treatment in Ankylosing Spondylitis

    JCR: Journal of Clinical Rheumatology

  4. Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: Lessons from a large population-based registry study

    Journal of Hematology and Oncology, Vol. 13, Núm. 1

2015

  1. Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus

    Clinical Infectious Diseases, Vol. 60, Núm. 6, pp. 950-958

2014

  1. Effects of sustained viral response in patients with HIV and chronic hepatitis C and nonadvanced liver fibrosis

    Journal of Acquired Immune Deficiency Syndromes, Vol. 66, Núm. 3, pp. 280-287

  2. Etravirine-based antiretroviral therapy in HIV/hepatitis C virus coinfected advanced fibrosis patients receiving triple therapy against hepatitis C virus with telaprevir

    AIDS

2011

  1. Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus

    Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 12, pp. 2843-2849

2010

  1. Infección por el VIH en el adulto: cambios epidemiológicos durante 25 años (1983-2008) en un área de la Comunidad de Madrid

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 28, Núm. 3, pp. 156-161

2009

  1. Cystatin C is associated with the metabolic syndrome and other cardiovascular risk factors in a hypertensive population

    Journal of the American Society of Hypertension, Vol. 3, Núm. 3, pp. 201-209

  2. Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis

    Journal of Acquired Immune Deficiency Syndromes, Vol. 50, Núm. 2, pp. 148-152

2008

  1. Biostatistics: A fundamental tool for the elaboration of radiological articles

    Radiologia, Vol. 50, Núm. 4, pp. 265-270

2007

  1. Economic evaluation of assistance to HIV patients in a Spanish hospital

    European Journal of Internal Medicine, Vol. 18, Núm. 5, pp. 400-404

2005

  1. Lipid disorders in antiretroviral-naive patients treated with lopinavir/ritonavir-based HAART: Frequency, characterization and risk factors

    Journal of Antimicrobial Chemotherapy, Vol. 55, Núm. 5, pp. 800-804

  2. Validación del cuestionario de satisfacción con el tratamiento antirretroviral: Cuestionario CESTA

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 23, Núm. 10, pp. 586-592

2002

  1. Estudio epidemiológico retrospectivo sobre la duración del tratamiento de la infección por el virus de la inmunodeficiencia humana en España

    Medicina Clinica, Vol. 119, Núm. 19, pp. 721-724